Jobs
View more job listings or post a job
AMOGH PHARMACEUTICALS: THE UNIVERSITY OF RHODE ISLAND USA. SUITABLE.
AMOGH PHARMA HEALTH PULSER: MUMBAI: INDIA SUITABLE.
MilliporeSigma Emerging Biotech Market Development Manager - San Fransisco
How Cancer LLC Social Media Digital Marketing Specialist  
How Cancer LLC Syndicated National Writer - Cancer 
University of California, Davis SCREENING SUPERVISOR
InnoAlliance Scientist/Sr Scientist of Bioanalysis & Biomarkers
AMOGH PHARMA HEALTH PULSE SUITABLE
AMOGH PHARMA HEALTH PULSE SUITABLE
Bioduro-Sundia Associate Director/Director in Laboratory Animal and Exploratory Toxicology
Post a job
Symposium

[Free Online] Advances in Cancer Therapeutics (Organized by PBSS and BioScience Forum)


Speakers: Darrin Stuart, Scorpion Therapeutics; Jan Smith, Revolution Medicines; Shirley Liu, GV20 Therapeutics; Thierry Guillaudeux, CSO, Kineta; Sumith Kularatne, On Target Laboratories; Eric Blouin, Ipsos; Michael Pehl, Adcendo; Allen S. Yang, Summit Therapeutics; Samuel C. Blackman, Day One Biopharmaceuticals; Mark W. Frohlich, Indapta Therapeutics; Hequn Yin, Iovance Biotherapeutics; Jakob Dupont, Sofinnova Investments
Organizers: Toby Freedman (Synapsis Search Recruiting and Author), Joe Carlino (Carlino Consulting), Donald McCarthy (Dawn Biopharma), Betty Chang (Summit Therapeutics), Wenfeng Xu (Chantibody Therapeutics), Snow Ge (BridgeBio Pharma), Shichang Miao (PBSS)
Date: 2024-08-14- 8/15/2024
Time: 8:30-13:15 Pacific Time
Registration fee: Free
Location: Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2024-08-13  (it will close sooner if the seating cap is reached)

About the Topic

This two-day symposium will discuss the latest advances in the discovery and development of cancer therapeutics from leading pharmaceutical companies and promising biotech companies.

Preliminary Agenda

Day 1, August 14

Time (PST) Topic Presenter(s)
8:30-9:00 am PBSS and BioScience Forum Welcome and Introduction, Symposium Overview, Agenda Review Shichang Miao, PhD, PBSS;  Joe Carlino, PhD, BioScienceForum
9:00-9:35 am Discovery and Development of Mutant-Selective PI3Kα Inhibitors Darrin Stuart, PhD, CSO, Scorpion Therapeutics
9:35-10:10 am Targeting Oncogenic RAS with Tri-Complex Inhibitors Jan Smith, PhD, CSO, Revolution Medicines
10:10-10:45 am Integrated Computation and Genomics for Cancer Target and Drug Discovery Shirley Liu, PhD, CEO, GV20 Therapeutics
10:45-11:00 am Break -
11:00-11:35 am Immunosuppressive Myeloid Cells – an Emerging Target in Cancer Immunotherapy Thierry Guillaudeux, PhD, CSO, Kineta
11:35 am-12:10 pm Targeted Drugs for Cancer Sumith Kularatne, PhD, Executive Vice President - R&D, On Target Laboratories
12:10-12:45 pm Tumor Infiltrating Lymphocytes for Treating Solid Tumors Hequn Yin, PhD, SVP, Head of Research, Iovance Biotherapeutics
12:45-1:15 pm Panel discussion All presenters

Day 2, August 15

Time (PST) Topic Presenter(s)
8:30-8:35 am Welcome and Introduction, Symposium Overview Dean Wilson, PhD, PBSS
8:35-9:10 am First-in-Class ADC for Hard-to-Treat Solid Tumor Cancers Michael Pehl, Dipl, CEO, Adcendo
9:10-9:45 am Development of Bispecific Antibodies for Cancer Allen S. Yang, MD, PhD, CMO, Summit Therapeutics
9:45-10:20 am From Concept to Proof: A New Model for Accelerating Pediatric Cancer Drug Development Samuel C. Blackman, MD, PhD, Founder and Head of R&D, Day One Biopharmaceuticals
10:20-10:35 am Break -
10:35-11:10 am Harnessing the Power of Naturally Occurring NK Cells to Fight Cancer & Autoimmune Disease Mark Frohlich, MD, CEO, Indapta Therapeutics
11:10 am-11:45 pm Oncology Drug Approvals: A Review of Recent Practice-Changing Approvals and a Look at the Near-Term Pipeline Eric Blouin, BM, Senior Vice Presiden -Oncology, Ipsos
11:45-12:20 pm The Outlook for Innovation in Cancer Therapeutics: A VC Perspective Jakob Dupont, MD, MA, Executive Partner, Sofinnova Investments
12:20-12:50 pm Panel discussion All presenters

Other Events of PBSS-San Francisco Bay:

2025-01-22, [In-Person] Small-Molecule Formulation for Discovery & Early Development (jointly by PBSS / AAPS-BADG / Syner-G)
2025-02-06, [In-Person] Intellectual Property (IP) Strategies and Best Practices
2025-02-13, [Free Online] The Science and Stories of Promising Biotech Startups
2025-02-26, [In-Person] Demystifying Biopharma Business Development: Understanding the Process and Thriving as a BD Professional
2025-03-07, [In-Person] Clinical Trial Planning and Conduct: Fundamentals, Strategies and Best Practices
2025-03-27, [Free Online Workshop] Biotech Financing 101: from Angels, Government Agencies, Foundations and VCs
2025-04-09, [In-Person] Cell Therapy Discovery and Development: Fundamentals, Strategies and Best Practices (jointly by PBSS and RAPS-SF)
2025-04-22, [Free Online Workshop] Career Transition Workshop: BD/Sales/Marketing at Vendors/Contract Organizations
2025-04-25, [In-Person] Drug Metabolism Fundamentals and Metabolite Identification
©Pharmaceutical & BioScience Society, International; Last Modified: 12/21/2024; Admin Logon
 Ads (in random order)
Submit a Text Ad
($250 for 2 months)
Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Hypha Discovery Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
Aliri Bioanalysis to the rescue! Pioneers in LCMS & Oligo bioanalysis w/ 30+ years of experience putting dev. programs back on track with quality data & fast timelines.
Submit a Text Ad